TheProfitWatch

TPST - Tempest Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
12.15 -0.27 (-2.22%) --- --- 0.0 (0.0%) 0.0 (0.0%) -0.34 (-2.83%) 0.0 (0.0%) 0.0 (0.0%)

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-2.07
Diluted EPS:
-2.07
Basic P/E:
-5.7391
Diluted P/E:
-5.7391
RSI(14) 1m:
100.0
VWAP:
11.88
RVol:
0.885

Events

Period Kind Movement Occurred At
1m Price decrease 1m 11.85 -0.13 (-1.09%) Oct 15 10:18
10m Price increase 10m 12.25 +0.38 (+3.2%) Oct 14 17:38

Related News